Menu

Panbela Therapeutics, Inc. PBLA

Full chart Compare
Set alert

Price alert · PBLA

All alert types
0.01 USD 0.00 (+0.00%)

At closeNov 5, 2026, 4:00 PM EST

0.02 Day range 0.02
0.0001 52-week range 0.05
YTD
+5,450.00%
1 year
-44.50%

Revenue & Expenses

Other Income → Expenses: $18.41KExpenses → Selling, General & Admin: $197.57KExpenses → Research & Development: $279.79KExpenses → Other Operating Expenses: $132.30KExpenses → Interest Expense: $35.89KExpenses → Income Tax: $220Gross Profit → Expenses: $415.35KRevenue → Gross Profit: $415.35KRevenue → Cost of Revenue: $558.47KNet Loss → Expenses: $212.02KOther Income$18.41KGross Profit$415.35KNet Loss$212.02KCost of Revenue$558.47KExpenses$645.78KSelling, General & Admin$197.57KResearch & Development$279.79KOther Operating Expenses$132.30KInterest Expense$35.89KIncome Tax$220Revenue$973.81K

Latest period ending Dec 31, 2022 · select a line to chart its full history

PBLA annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
-34.09M-10.01M-5.75M-4.32M-3.89M
-34.93M-10.13M-4.77M-6.20M-5.91M
-40,746.00-20,784.00-14,880.00-26,160.00-30,480.00
PBLA annual balance sheet
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
1.28M11.87M9.02M2.45M1.41M
4.98M12.87M9.81M3.14M1.90M
13.03M2.66M1.36M1.76M1.63M
6.84M00858.00K350.00K
-8.05M10.21M8.45M1.39M268.00K
PBLA annual cash flow
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
-15.28M-7.25M-3.85M-2.74M-2.39M
-656.00K0000
5.35M10.10M10.44M3.78M3.64M
-10.58M2.85M6.57M1.04M1.25M